Cargando…
The role of metabotropic glutamate receptor 5 in the pathogenesis of mood disorders and addiction: combining preclinical evidence with human Positron Emission Tomography (PET) studies
In the present review, we deliver an overview of the involvement of metabotropic glutamate receptor 5 (mGluR5) activity and density in pathological anxiety, mood disorders and addiction. Specifically, we will describe mGluR5 studies in humans that employed Positron Emission Tomography (PET) and comb...
Autores principales: | Terbeck, Sylvia, Akkus, Funda, Chesterman, Laurence P., Hasler, Gregor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364244/ https://www.ncbi.nlm.nih.gov/pubmed/25852460 http://dx.doi.org/10.3389/fnins.2015.00086 |
Ejemplares similares
-
Metabotropic glutamate receptor 5 in bulimia nervosa
por: Mihov, Yoan, et al.
Publicado: (2020) -
Metabotropic glutamate receptor 5 binding in male patients with alcohol use disorder
por: Akkus, Funda, et al.
Publicado: (2018) -
Negative Allosteric Modulators of Metabotropic Glutamate Receptors Subtype 5 in Addiction: a Therapeutic Window
por: Mihov, Yoan, et al.
Publicado: (2016) -
Radiosynthesis and Evaluation of an (18)F-Labeled
Positron Emission Tomography (PET) Radioligand for Metabotropic Glutamate
Receptor Subtype 4 (mGlu(4))
por: Kil, Kun-Eek, et al.
Publicado: (2014) -
(11)C-LY2428703, a positron emission tomographic radioligand for the metabotropic glutamate receptor 1, is unsuitable for imaging in monkey and human brains
por: Zanotti-Fregonara, Paolo, et al.
Publicado: (2013)